NCT05671055 - CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 7, 2023

Primary Completion Date

December 6, 2023

Study Completion Date

December 6, 2023

Conditions

Multiple Sclerosis

Interventions

OTHER

Custom study version of icompanion app

Patients complete patient-reported outcomes on cognition and covariates, as well as objective cognitive tests through a version of icompanion app customized specifically for this study. Patients complete all assessments remotely in an at-home situation.

Trial Locations (10)

1090

UZ Brussel, Jette

2018

GZA Antwerpen, Antwerp

2820

Imelda Ziekenhuis, Bonheiden

8000

AZ Sint-Jan Brugge, Bruges

14226

Dent Neurologic Institute, Buffalo

17489

University of Greifswald, Greifswald

43235

The Boster Center for Multiple Sclerosis, Columbus

75206

Texas Neurology, Dallas

80045

UCHealth, Aurora

80528

Brain Health Center of the Rockies, Fort Collins